QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2014     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Low dose of interferon-α improves the clinical outcomes of docetaxel in patients with castration-resistant prostate cancer: A pilot study. 期刊论文 Oncology letters, 2014, 卷号: 7, 期号: [db:dc_citation_issue], 页码: 125-130 作者:  Li Yun-Fei;  Wang Qin-Zhang;  Zhang Tao-Tao;  Li Lei;  Wang Jiang-Ping 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/03 interferon-&alpha  -2b  castration-resistant prostate cancer  docetaxel   Linc00963: A novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence 期刊论文 INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 卷号: 44, 期号: [db:dc_citation_issue], 页码: 2041-2049 作者:  Wang, Lijuan;  Han, Suxia;  Jin, Guihua;  Zhou, Xia;  Li, Meng 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/03 long non-coding RNA  epidermal growth factor receptor  castration-resistant prostate cancer  Linc00963  AKT   Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-Resistant prostate cancer cell line, PC3 期刊论文 UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 卷号: 32, 期号: 5, 页码: 720-726 作者:  Ding, Huan;  Sun, Ying;  Hou, Yu;  Li, Li 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/17 INPP4B  Combined  PARP inhibitor  Castration therapy-resistant prostate  cancer  PC3  PTEN   Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer 期刊论文 KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2014, 卷号: 30, 期号: 2 作者:  Zhu, Yi-Ping;  Yao, Xu-Dong;  Zhang, Shi-Lin;  Dai, Bo;  Zhang, Hai-Liang 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Castration-resistant prostate cancer  Chemotherapy  Etoposide  Oral   Efficacy and Toxicity of Anti-VEGF Agents in Patients with Castration-Resistant Prostate Cancer: a Meta-analysis of Prospective Clinical Studies 期刊论文 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 卷号: 15, 期号: 19 作者:  Qi, Wei-Xiang;  Fu, Shen;  Zhang, Qing;  Guo, Xiao-Mao 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19 VEGF inhibitors  angiogenesis inhibitors  castration-resistant prostate cancer  efficacy